MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
23:55
The US sanctions Russia’s second-largest bank / Washington accuses VTB Bank of helping Iran evade sanctions
23:24
Russia will temporarily halt gas supplies to Armenia for maintenance work, amid tensions between Moscow and Yerevan
23:14
Alexandru Nazare welcomes the decrease in inflation, but warns that Romania cannot afford to abandon fiscal adjustment
23:00
Hubble and James Webb have identified 27 new objects beyond Neptune’s orbit
22:58
Volodymyr Zelenskyy dismissed Prosecutor General Ruslan Kravchenko, who was accused of corruption
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
